Unlocking New Therapeutic Avenues: Our Third Drug Discovery Seminar Explores the Promise of RNA Modulators

We were thrilled to welcome Rachel Moore from AstraZeneca last week for the third installment of our Drug Discovery Seminar series. Rachel delivered a truly insightful presentation on the fascinating and rapidly evolving field of hit discovery of small molecule RNA modulators.

Her talk beautifully highlighted both the immense potential and the inherent challenges in developing small molecules that can precisely target and modulate RNA function. The presentation sparked a wealth of insightful questions and lively discussions, reflecting the high level of interest and the cutting-edge nature of this research area. We extend our sincere gratitude to Rachel Moore for sharing her knowledge and insights with our community.

Finally, a big thank you to everyone who joined us for this engaging seminar.

Stay tuned for updates on our upcoming seminars and other exciting developments!